Showing results (171-180 of 435) with videos related to
Sort By:
Pageof 44
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2018
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's LymphomasCarlos A Ramos, Rayne Rouce, Catherine S Robertson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2018
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin LymphomaCatherine M Bollard, Tamara Tripic, Conrad Russell Cruz, et al.Blood|April 23, 2014
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneXiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, et al.JACC. Heart Failure|July 18, 2026
Functional Status and Health-Related Quality of Life Among Survivors of Cardiogenic ShockEric J Hall, Sachin Agarwal, Colby R Ayers, et al.Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell TransplantationIfigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, et al.The American Journal of Cardiology|January 26, 2025
Patient Characteristics, Management and Long-Term Outcomes of Patients With Cardiogenic Shock at a Large Safety Net HospitalEric J Hall, Colby R Ayers, Nicholas S Hendren, et al.Circulation Research|December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year AnalysisJay H Traverse, Timothy D Henry, Carl J Pepine, et al.Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.Pageof 44